Alcon Pharmaceuticals Ltd. v. Akorn, Inc.
1:15-cv-00948
Overview
Parties
Defendant
Akorn, Inc. Operating Company
Represented By
1 Attorneys ListedPolsinelli PC
222 Delaware Avenue, Suite 1101, Wilmington, DE 19801
Plaintiff
Alcon Research, Ltd. Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Alcon Pharmaceuticals Ltd. Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 7 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 6,716,830 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 7,671,070 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,673,902 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,993,636 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 10,250,498 P | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 10,250,698 P | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 64,679,700 A | US Continuation / Sibling | View Official Patent → |
Apotex Inc. v. Alcon Pharmaceuticals Ltd.
Alcon Pharmaceuticals Ltd. v. Imprimis Pharmaceuticals, Inc.
Alcon Pharmaceuticals Ltd v. Aurobindo Pharma Ltd.
Alcon Pharmaceuticals Ltd v. Lupin Ltd.
Alcon Pharmaceuticals Ltd v. Apotex Inc.
Alcon Pharmaceuticals Ltd v. Watson Laboratories Inc.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6716830
Ophthalmic antibiotic compositions containing moxifloxacin
|
Filed: 2002-07-22
Issued: 2004-04-06
|
Expired (Term Ended)
Expires: 2022-07-22
|
|
|
US7671070
Method of treating ophthalmic infections with moxifloxacin compositions
|
Filed: 2003-11-17
Issued: 2010-03-02
|
Expired (Term Ended)
Expires: 2023-11-17
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).